EY Firepower Report: Life Sciences Dealmaking and M&A Growth Strategy
Life sciences dealmaking volume is stable, but value is down. Explore how life sciences companies can secure a more confident future with smarter, smaller deals.
EY Biotech Beyond Borders Report 2025
As biopharma companies face a rapidly changing political landscape, we explore industry performance over the last year, including strategies that will position companies for long-term success.
Optimizing Health Outcomes for All Report
Discover key insights that highlight strategic priorities and investments to enhance care across sectors, along with the evolution of organizational capabilities, based on a survey of 500 industry leaders.
Access report
Access report
Access report
Access report
Access report
Access report
Learn how MedTech companies are reigniting growth and expanding markets, with the industry's annual revenue growing for the seventh straight year, reaching almost US$600 billion for the first time.
Pulse of the MedTech Industry Report 2025
Access report
Life sciences dealmaking volume is stable, but value is down. Explore how life sciences companies can secure a more confident future with smarter, smaller deals.
EY Firepower Report: Life Sciences Dealmaking and M&A Growth Strategy
